Safe Injection Sites

RSS Feed for this category

Chronicle AM: Mexico Legalizes MedMJ, China Bans More Synthetic Opioids, More... (6/20/17)

New Jersey pols look to legalize pot next year, Vermont pols look to legalize it this week, China bans more synthetic opioids, Mexico officially embraces medical marijuana, and more.

Medical marijuana is now officially legal in Mexico, but rules and regulations will take some time.
Marijuana Policy

New Jersey Legalization Bill Gets Hearing. The Senate Judiciary Committee held a hearing on a legalization measure, Senate Bill 3195, on Monday. The testimony was largely favorable, including from a former state Republican Committee head, the head of a doctors' organization favoring legalization, and from a long-time municipal prosecutor. "I believe by legalizing and regulating it and discouraging, officially as official government policy, like we do with tobacco and alcohol, we will be far better off than the status quo," prosecutor J.H. Barr told the committee. No vote was taken. The bill is strongly opposed by Gov. Chris Christie (R), but he'll be gone in January.

Vermont Legislators Will Try to Get Weed Legalized in Special Session This Week. Gov. Phil Scott (R) vetoed the legalization bill in May, saying he had public safety concerns. Supporters of legalization have come back with a bill that now has stiffer penalties for drugged driving, smoking pot in cars with kids, providing pot to kids, and selling pot in school zones -- all in a bid to win the governor's support. The bill does not include "impairment testing mechanism" requested by Scott, largely because there are no marijuana breathalyzers on the market. Scott has declined to comment on the revised bill. The special session begins Wednesday.

Harm Reduction

Boston Ponders Supervised Injection Sites. With six people a day dying of opioid overdoses in the city so far this year, the city council has set a hearing next Monday to explore the potential impact of supervised injection sites. The move comes after the Massachusetts Medical Society urged state officials to open at least two of the facilities.

International

China Bans Synthetic Opioids Linked to US Overdose Deaths. China announced on Monday that it is banning the ultra-potent synthetic opioid U-47700 and three others. The DEA says China is the chief source of synthetic opioids, including fentanyl and carfentanil, which China has already banned. U-47700, MT-45, PMMA, and 4,4-DMAR will be added to the country's list of controlled substances as of July 1, said Deng Ming, deputy director of the National Narcotics Control Commission.

Mexico Legalizes Medical Marijuana. President Enrique Pena Nieto issued a decree on Monday officially legalizing medical marijuana in the country. Legislation authorizing medical marijuana sailed through the Senate in December and passed the lower house on a 347-7 vote in April. Now, the Ministry of Health will be tasked with drafting and implementing rules and regulations.

America, We Can Fix This: 24 Ways to Reduce Opioid Overdoses and Addiction [FEATURE]

Drugs, mainly opioids, are killing Americans at a record rate. The number of drug overdose deaths in the country quadrupled between 1999 and 2010 -- and compared to the numbers we're seeing now, those were the good old days.

Some 30,000 people died of drug overdoses in 2010. According to a new estimate from the New York Times, double that number died last year. And the rate of increase in overdose deaths was growing, up a stunning 19% over 2015.

The Times' estimate of between 59,000 and 65,000 drug overdose deaths last year is greater than the number of American soldiers killed during the entire Vietnam War, greater than that number of people killed in the peak year for car crash deaths, greater than the number of people who died in the year the AIDS epidemic peaked, and higher than the peak year for gun deaths.

In the first decade of the century, overdoses and addiction rose in conjunction with a dramatic increase in prescription opioid prescribing; since then, as government agents and medical professionals alike sought to tamp down prescribing of opioids, the overdose wave has continued, now with most opioid OD fatalities linked to illicit heroin and powerful black market synthetic opioids, such as fentanyl and carfentanil.

The Centers for Disease Control and Prevention says we are in the midst of "the worst drug overdose epidemic in history," and it's hard to argue with that.

So, what do we do about it? Despite decades of failure and unintended consequences, the prohibitionist reflex is still strong. Calls for more punitive laws, tougher prosecutorial stances, and harsher sentences ring out from state houses across the land to the White House. But tough drug war policies haven't worked. The fact that the overdose and addiction epidemic is taking place under a prohibition regime should make that self-evident.

More enlightened -- and effective -- approaches are now being tried, in part, no doubt, because today's opioid epidemic is disproportionately affecting white, middle class people and not the inner city black people identified with heroin epidemics of the past. But they are also being tried because for the past quarter-century an ever-growing drug reform movement has articulated the failures of prohibition and illuminated more effective alternatives.

The drug reform movement's most powerful organization, the Drug Policy Alliance, this spring published A Public Health and Safety Approach to Problematic Opioid Use and Overdose, which lays out more than two dozen specific policy prescriptions in the realms of addiction treatment, harm reduction, prevention, and criminal justice that have been proven to save lives and reduce dependency on opioids. These policy prescriptions are doable now -- and some are being implemented in some fashion in some places -- but require that political decisions be made, or that forces be mobilized to get those decisions made. Some would require a radical divergence from the orthodoxies of drug prohibition, but that's a small price to pay given the mounting death toll.

Here are 24 concrete policy proposals that can save lives and reduce addiction right now. All the facts and figures are fully documented in the heavily-annotated original. Consult it if you want to get down to the nitty-gritty. In the meantime:

Addiction Treatment

1. Create Expert Panel on Treatment Needs: States should establish an expert panel to address effective treatment needs and opportunities. The expert panel should evaluate barriers to existing treatment options and make recommendations to the state legislature on removing unnecessary impediments to accessing effective treatment on demand. Moreover, the panel should determine where gaps in treatment exist and make recommendations to provide additional types of effective treatment and increased access points to treatment (such as hospital-based on demand addiction treatment). The expert panel must also set evidence-based standards of care and identify the essential components of effective treatment and recovery services to be included in licensed facilities, especially with regards to medication-assisted treatment, admission requirements, discharge, continuity of care and/or after-care, pain management, treatment programming, integration of medical and mental health services, and provision of or referrals to harm reduction services. The expert panel should identify how to improve or create referral mechanisms and treatment linkages across various healthcare and other providers. The panel should establish clear outcome measures and a system for evaluating how well providers meet the scientific requirements the panel sets. And, finally, the expert panel should evaluate opportunities under the ACA to expand coverage for treatment.

2. Increase Insurance Coverage for Medication-Assited Treatment (MAT): Seventeen state medical plans under the Patient Protection and Affordable Care Act (ACA) do not provide coverage for methadone or buprenorphine for opioid dependence. Moreover, the Veterans Administration's (VA's) insurance system has explicitly prohibited coverage of methadone and buprenorphine treatment for active duty personnel or for veterans in the process of transitioning from Department of Defense care. As a result, veterans obtaining care through the VA are denied effective treatment for opioid dependence. Insurance coverage for these critical medications should be standard practice.

3. Establish and Implement Office-Based Opioid Treatment for Methadone: Currently, with a few exceptions, methadone for the treatment of opioid dependence is only available through a highly regulated and widely stigmatized system of Opioid Treatment Programs (OTPs). Moreover, several states have imposed moratoriums on establishing new OTPs that facilitate methadone treatment despite large, unmet treatment needs for a growing opioid-dependent population. Patients enrolled in methadone treatment in many communities are often limited to visiting a single OTP and face other inconveniences that make adherence to treatment more difficult. Initial trials have suggested that methadone can be effectively delivered in office-based settings and that, with training, physicians would be willing to prescribe methadone to their patients to treat their opioid dependence. Office-based methadone may help reduce the stigma associated with methadone delivered in OTPs as well as provide a critical window of intervention to address medical and psychiatric conditions. Office-based opioid treatment programs offering methadone have been implemented in California, Connecticut, and Vermont.

4. Provide MAT in Criminal Justice Settings, Including Jails/Prisons and Drug Courts: Individuals recently released from correctional settings are up to 130 times more likely to die of an overdose than the general population, particularly in the immediate two weeks after release. Given that approximately one quarter of people incarcerated in jails and prisons are opioid-dependent, initiating MAT behind bars should be a widespread, standard practice as a part of a comprehensive plan to reduce risk of opioid fatality. Jails should be mandated to continue MAT for those who received it in the community and to assess and initiate new patients in treatment. Prisons should initiate methadone or buprenorphine prior to release, with a referral to a community-based clinic or provider upon release. In addition, drug courts should be mandated to offer participants the option to participate in MAT if they are not already enrolled, make arrangements for their treatment, and should not be permitted to make discontinuation of MAT a criterion for successful completion of drug court programs. The Substance Abuse and Mental Health Services Administration will no longer provide federal funding to drug courts that deny the use of MAT when made available to the client under the care of a physician and pursuant to a valid prescription. The National Association of Drug Court Professionals agrees: "No drug court should prohibit the use of MAT for participants deemed appropriate and in need of an addiction medication."

Medication-Assisted Treatment (MAT) can help.
5. Offer Hospital-Based MAT: Emergency departments should be mandated to inform patients about MAT and offer buprenorphine to those patients that visit emergency rooms and have an underlying opioid use disorder, with an appointment for continued treatment with physicians in the community. Hospitals should also offer MAT within the inpatient setting, and start MAT prior to discharge with community referrals for ongoing MAT.

6. Assess Barriers to Accessing MAT to Increase Access to Methadone and Buprenorphine: A number of known barriers prevent MAT from being as widely accessible as it should be. The federal government needs to reevaluate the need for and effectiveness of the OTP model and make necessary modifications to ensure improved and increased access to methadone. And, while federal law allows physicians to become eligible to prescribe buprenorphine for the treatment of opioid dependence, it arbitrarily caps the number of opioid patients a physician can treat with buprenorphine at any one time to 30 through the first year following certification, expandable to up to potentially 200 patients thereafter. Moreover, states need to evaluate additional barriers created by state law, including, among others, training and continuing education requirements, restrictions on nurse practitioners, insurance enrollment and reimbursement, and lack of provider incentives.

7. Establish and Implement a Heroin-Assisted Treatment Pilot Program: Heroin-assisted treatment (HAT) refers to the administering or dispensing of pharmaceutical-grade heroin to a small and previously unresponsive group of chronic heroin users under the supervision of a doctor in a specialized clinic. The heroin is required to be consumed on-site, under the watchful eye of trained professionals. This enables providers to ensure that the drug is not diverted, and allows staff to intervene in the event of overdose or other adverse reaction. Permanent HAT programs have been established in the United Kingdom, Switzerland, the Netherlands, Germany and Denmark, with additional trial programs having been completed or currently taking place in Spain, Belgium and Canada. Findings from randomized controlled studies in these countries have yielded unanimously positive results, including: 1) HAT reduces drug use; 2) retention rates in HAT surpass those of conventional treatment; 3) HAT can be a stepping stone to other treatments and even abstinence; 4) HAT improves health, social functioning, and quality of life; 5) HAT does not pose nuisance or other neighborhood concerns; 6) HAT reduces crime; 7) HAT can reduce the black market for heroin; and, 8) HAT is cost-effective (cost-savings from the benefits attributable to the program far outweigh the cost of program operation over the long-run). States should consider permitting the establishment and implementation of a HAT pilot program. Nevada and Maryland have introduced legislation of this nature and the New Mexico Legislature recently convened a joint committee hearing to query experts about this strategy.

8. Evaluate the Use of Cannabis to Decrease Reliance on Prescription Opioids and Reduce Opioid Overdose Deaths: Medical use of marijuana can be an effective adjunct to or substitute for opioids in the treatment of chronic pain. Research published last year found 80 percent of medical cannabis users reported substituting cannabis for prescribed medications, particularly among patients with pain-related conditions. Another important recent study reported that cannabis treatment "may allow for opioid treatment at lower doses with fewer [patient] side effects." The result of substituting marijuana, a drug with less side effects and potential for abuse, has had profound harm reduction impacts. The Journal of the American Medical Association, for instance, documents a relationship between medical marijuana laws and a significant reduction in opioid overdose fatalities: "[s]tates with medical cannabis laws had a 24.8% lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws."Another working paper from the RAND BING Center for Health Economics notes that "states permitting medical cannabis dispensaries experienced a 15 to 35 percent decrease in substance abuse admissions and opiate overdose deaths." There is also some emerging evidence that marijuana has the potential to treat opioid addiction, but additional research is needed.

Harm Reduction

9. Establish and Implement Safe Drug Consumption Services: States and/or municipalities should permit the establishment and implementation of safe drug consumption services through local health departments and/or community-based organizations. California and Maryland have introduced legislation to establish safe drug consumption services, and the City of Ithaca, New York has included a proposal for a supervised injection site in their widely-publicized municipal drug strategy. In Washington State, the King County Heroin an Prescription Opiate Addiction Task Force has recommended the establishment of at least two pilot supervised consumption sites as part of a community health engagement program designed to reduce stigma and "decrease risks associated with substance use disorder and promote improved health outcomes" in the region that includes the cities of Seattle, Renton and Auburn.

10. Maximize Naloxone Access Points, Including Lay Distribution and Pharmacy Access, As Well As Immunities for Prescription, Distribution and Administration:Naloxone should be available directly from a physician to either a patient or to a family member, friend, or other person in a position to assist in an overdose, from community-based organizations through lay distribution or standing order laws, and from pharmacies behind-the-counter without a prescription through standing order, collaborative agreement, or standardized protocol laws or regulations. Though some states, including California, New York, Colorado and Vermont, among others, have access to naloxone at each of these critical intervention points, many others only provide naloxone through a standard prescription. Civil and criminal immunities should be provided to prescribers, dispensers and lay administrators at every access point. In addition, all first responders, firefighters and law enforcement should be trained on how to recognize an overdose and be permitted to carry and use naloxone. Naloxone should also be reclassified as an over-the-counter (OTC) medication. Having naloxone available over-the-counter would greatly increase the ability of parents, caregivers, and other bystanders to intervene and provide first aid to a person experiencing an opioid overdose. FDA approval of OTC naloxone is predicated on research that satisfies efficacy and safety data requirements. Pharmaceutical companies, however, have not sought to develop an over-the-counter product.88 Federal funding may be needed to meet FDA approval requirements.

11. Provide Dedicated Funding for Community-Based Naloxone Distribution and Overdose Prevention and Response Education: Few states provide dedicated budget lines to support the cost of naloxone or staffing for community-based opioid overdose prevention programs. The CDC, however, reports that, between 1996 and 2014, these programs trained and equipped more than 152,280 laypeople with naloxone, who have successfully reversed 26,463 opioid overdoses.89 Without additional and dedicated funding, community-based opioid overdose prevention programs will not be able to continue to provide naloxone to all those who need it, and the likelihood of new programs being implemented is slim. A major barrier to naloxone access is its affordability and chronic shortages in market supply, 90 which overdose prevention programs, operating on shoestring budgets, can have a difficult time navigating.

12. Improve Insurance Coverage for Naloxone: Individuals who use heroin and other opioids are often both uninsured and marginalized by the healthcare system.91 States should insure optimal reimbursement rates for naloxone to increase access to those who need it most – users themselves.

Overdose reversal drugs need to be made much more widely available -- and affordable. (health.pa.gov)
13. Provide Naloxone to Additional At-Risk Communities: People exiting detox and other treatment programs as well as periods of incarceration are at particularly high risk for overdose because their tolerance has been substantially decreased. After their period of abstinence, if they relapse and use the same amount, the result is often a deadly overdose. States should require overdose education and offer naloxone to people upon discharge from detox and other drug treatment programs and jails/prisons. The Substance Abuse and Mental Health Services Administration has declared that prescribing or dispensing naloxone is an essential complement to both detoxification services as well as medically supervised withdrawal. Vermont passed legislation making naloxone available to eligible pilot project participants who are transitioning from incarceration back to the community. In addition, there are other programs/studies that provide naloxone to recently released individuals on a limited basis, including in San Francisco, California, King County, Washington and Rhode Island.

14. Encourage Distribution of Naloxone to Patients Receiving Opioids: Physicians should be encouraged to prescribe naloxone to their patients and opioid treatment programs should inform their clients about naloxone, if prescribing or dispensing an opioid to them. Pharmacists should similarly be encouraged to offer naloxone along with all Schedule II opioid prescriptions being filled, for syringe purchases (without concurrent injectable medication), and for all co-prescriptions (within 30 days) of a benzodiazepine (such as Valium™, Xanax™ or Klonopin™) and any opioid medication. The Rhode Island Governor's Overdose Prevention and Intervention Task Force found that offering naloxone to those prescribed a Schedule II opioid or when co-prescribed a benzodiazepine and any opioid would have reached 86% of overdose victims who received a prescription from a pharmacy prior to their death, and could have prevented 58% of all overdose deaths from 2014 to 2015.

15. Expand Good Samaritan Protections: "Good Samaritan" laws provide limited immunity from prosecution for specified drug law violations for people who summon help at the scene of an overdose. But, protection from prosecution is not enough to ensure that people are not too frightened to seek medical help. Other consequences, like arrest, parole or probation violations, and immigration consequences, can be equal barriers to calling 911. States with Good Samaritan laws already on the books should evaluate the protections provided and determine whether expansion of those protections would increase the likelihood that people seek medical assistance.

16. End the Criminalization of Syringe Possession: Syringes should be exempt from state paraphernalia laws in order to provide optimal access to people who inject drugs. Twenty-two states criminalize syringe possession. Thus, even if there is a legal access point, such as pharmacy sales, paraphernalia laws still permit law enforcement to arrest and prosecute individuals in possession of a syringe. Public health and law enforcement authorities should not be working at cross-purposes.

17. Reduce Barriers to Over-The-Counter Syringe Sales and Permit Direct Prescriptions of Syringes: While the non-prescription, over-the-counter sale of syringes is now permitted in all but one U.S. state, access is still unduly restricted.States should evaluate the potential barriers to accessing syringes over-thecounter and implement measures to improve access. Moreover, doctors should be permitted to prescribe syringes directly to their patients, a practice few states currently permit.

18. Authorize and Fund Sterile Syringe Access and Exchange Programs; Increase Programs: States should explicitly authorize and fund sterile syringe access and exchange programs, and states that have already authorized them should evaluate how to increase the number or capacity of programs to ensure all state residents – whether in urban centers or rural communities -- have access to clean syringes, as well as evaluate any possible barriers to access such as unnecessary age restrictions.

19. Provide Free Public, Community-Level Access to Drug Checking Services: Technology exists to test heroin and opioid products for adulterants via GC/MS analysis, but it has so far been unavailable at a public level in the US (aside from a mail-in service run by Ecstasydata.org). Making these services available in the context of a community outreach service or academic study would lower the number of deaths and hospitalizations and also allow for real-time tracking of local drug trends.

Prevention

20. Establish Expert Panel on Opioid Prescribing: Though the CDC has issued guidelines for prescribing opioids for chronic pain, the guidelines are voluntary and are likely to exacerbate disparities in treatment that already exist. Research has shown, for example, that African Americans are less likely than whites to receive opioids for pain even when being treated for the same conditions. Moreover, the CDC guidelines only address prescribing practices for chronic pain, not prescribing practices more broadly. States should accordingly establish an expert panel to undertake an assessment as to whether prescribing practices, such as co-prescriptions for benzodiazepines and opioids or overprescribing of opioids, have contributed to increased rates of opioid dependence, and, if so, the expert panel should develop a plan to address any such linkages as well as any treatment disparities. The plan must account for the potential negative effects of curtailing prescribing practices or swiftly reducing prescription opioid prescribing volume. A task force in Rhode Island found that while changes in opioid supply can have the intended effect of reducing availability of abuse-able medications, they have also been linked to an increase in transition to illicit drug use and in more risky drug use behaviors (e.g., snorting and injecting pain medications). The plan must also account for chronic pain patients, particularly those already underserviced, and not unduly limit their access to necessary medications. Finally, to the extent prescribing guidelines are issued as part of the plan, they should be mandatory and applied across the board.

21. Mandate Medical Provider Education: States should mandate that all health professional degree-granting institutions include curricula on opioid dependence, overdose prevention, medication-assisted treatment, and harm reduction interventions, and that continuing education on these topics be readily available.

22. Develop Comprehensive, Evidence-Based Health, Wellness, and Harm Reduction Curriculum for Youth: State education departments, in conjunction with an expert panel consisting of various stakeholders that ascribe to scientific principles of treatment for youth, should develop a comprehensive, evidence-based health, wellness, and harm reduction curriculum for use in schools that incorporates scientific education on drugs, continuum of use, and contributors to problematic drug use (e.g., coping and resiliency, mental health issues, adverse childhood experiences, traumatic events and crisis), as well as how reduce harm (e.g., not mixing opioids with benzodiazepines). Education departments should also establish protocols and resources for early intervention, counseling, linkage to care, harm reduction resources, and other supports for students.

CRIMINAL JUSTICE

23. Establish Diversion Programs, Including Law Enforcement Assisted Diversion (LEAD): LEAD is a pre-booking diversion program that establishes protocols by which police divert people away from the typical criminal justice route of arrest, charge and conviction into a health-based, harm-reduction focused intensive case management process wherein the individual receives support services ranging from housing and healthcare to drug treatment and mental health services. Municipalities should create and implement LEAD programs and states and the federal government should provide dedicated funding for such programs. Various other forms of diversion programs exist and can be implemented should LEAD prove unsuitable to a particular population or municipality.

24. Decriminalize Drug Possession: Decriminalization is commonly defined as the elimination of criminal penalties for drug possession for personal use. In other words, it means that people who merely use or possess small amounts of drugs are no longer arrested, jailed, prosecuted, imprisoned, put on probation or parole, or saddled with a criminal record. Nearly two dozen countries have taken steps toward decriminalization. Empirical evidence from the international experiences demonstrate that decriminalization does not result in increased use or crime, reduces incidences of HIV/AIDs and overdose, increases the number of people in treatment, and reduces social costs of drug misuse. All criminal penalties for possession of small amounts of controlled substances for personal use should be removed.

Chronicle AM: Supreme Court Restricts Forfeiture, Rejects College Drug Test Bid, More... (6/6/17)

The Supreme Court makes two good drug policy-related rulings in one day, the California Assembly approves both a marijuana "sanctuary" bill and a supervised injection site bill, last-ditch efforts to free the weed in Connecticut hit a bump, and more.

The Supreme Court rules favorably on two drug policy-related issues. (Wikimedia)
Marijuana Policy

California Assembly Passes Marijuana "Sanctuary" Bill. The Assembly has approved Assembly Bill 1578, which would prohibit state resources from being used to help enforce federal marijuana laws that conflict with state law. The bill from Assemblyman Reggie Jones-Sawyer (D-Los Angeles) now goes to the state Senate.

Connecticut Legalization Measure Still Stalled. The last-ditch effort to get legalization passed through the budget process broke down early Monday just minutes before a press conference announcing a compromise was to be announced. Rep. Melissa Ziobron (R-East Haddam) complained that she didn't see a copy of the legalization amendment until just minutes earlier, when she learned that Rep. Josh Elliot (D-Hamden) and other Democrats had been crafting the measure since last Friday. "This isn't about headlines. This isn't about a news conference," Ziobron said. "This is about what's good for the state of Connecticut, and doing it last-minute, doing it in a way that is not bipartisan, is very worrisome and should be for every single person in this state."

Nevada Republicans Kill Governor's Pot Tax Bill. A bill supported by Gov. Brian Sandoval (R) that would have imposed a 10% tax on recreational marijuana sales has been defeated in the Senate after Republicans refused to support it because of unrelated budget issues. The vote was 12-9 in favor, but because it was a budget bill, it needed a two-thirds majority, or 14 votes, to pass.

Medical Marijuana

Florida Governor Uses Line-Item Veto to Kill Medical Marijuana Research Projects. Gov. Rick Scott (R) used his line-item veto power to kill three line items that would have provided more than $3 million dollars to the Moffitt Cancer Center and the University of Florida for medical marijuana research. In his veto message, Scott wrote that the institutions had plenty of money to fund the research on their own.

Asset Forfeiture

Supreme Court Restricts Asset Forfeiture in Drug Cases. In a decision handed down Monday, the US Supreme Court has moved to restrict prosecutorial efforts to seize money or goods from drug defendants. In Honeycutt v. US, brothers Terry and Tony Honeycutt were convicted of selling methamphetamine precursor chemicals, and the feds then swooped in to seize $200,000 of the estimated $270,000 profits from the sales. But they then sought to seize the remaining $70,000 from Terry Honeycutt, who was only an employee at his brother's hardware store, and that crossed a line, the court said. "Congress did not authorize the government to confiscate substitute property from other defendants or coconspirators," Sotomayor said. "It authorized the government to confiscate assets only from the defendant who initially acquired the property and who bears responsibility for its dissipation."

Drug Testing

Supreme Court Refuses to Hear Appeal from Missouri Tech College That Wanted to Drug Test All Students. The US Supreme Court on Monday declined to hear an appeal from the State Technical College of Missouri of an appeals court ruling that its mandatory drug testing policy is unconstitutional when applied to all students. Lower courts had upheld mandatory suspicionless drug testing of only a handful of the school's disciplines where safety was a key element. "This case establishes -- once and for all -- that under the Fourth Amendment, every person has the right to be free from an unreasonable search and seizure, including college students," the ACLU, which filed the class-action lawsuit in 2011, said in a statement Monday.

Harm Reduction

California Assembly Passes Supervised Injection Sites Bill. The Assembly last Thursday approved Assembly Bill 186, which would allow for the provision of supervised drug consumption sites. The pioneering harm reduction measure sponsored by Assemblywoman Susan Talamantes Eggman (D-Stockton) now moves to the state Senate. "California is blazing a new trail toward a policy on drug addiction and abuse that treats it as the medical issue and public health challenge that it is, and not as a moral failing," said Talamantes Eggman. "We are in the midst of an epidemic, and this bill will grant us another tool to fight it -- to provide better access to services like treatment and counseling, to better protect public health and safety, and to save lives."

Chronicle AM: VT Gov Will Act on Legalization, Trump Retreats from ONDCP Defunding, More... (5/23/17)

Vermont Gov. Phil Scott says he will act on marijuana legalization tomorrow, the Trump budget reverses earlier plans to radically defund the drug czar's office, a new Michigan poll has good news for activists, and more.

Will Vermont's governor sign or veto the marijuana legalization bill? Check back tomorrow to find out. (Wikimedia.org)
Marijuana Policy

Michigan Poll Has Strong Majority for Legalization. A new poll from the Marketing Resource Group has support for marijuana legalization at 58%, if it is taxed and regulated like alcohol. The strongest support came from Democrats and people under 40. The poll comes as the Michigan Coalition to Regulate Marijuana Like Alcohol is beginning a signature gathering campaign to put its legalization initiative on the November 2018 ballot. "While attitudes toward marijuana may be mellowing, most Republican voters and those 65 and older still are not ready to legalize it," said Tom Shields, president of MRG. "Support for legalizing recreational use of marijuana has grown from 41 percent in 2013 to 58 percent in just the last four years. I would not be surprised to see a successful ballot proposal within the next few years."

Vermont Governor to Act on Legalization Bill Tomorrow. Gov. Phil Scott (R) said Tuesday he would either sign or veto Senate Bill 22 on Wednesday, the last possible day for him to act. Under state law, the bill could become law if Scott fails to act, but Scott said he would not let that happen and would either veto or sign the bill. If he signs it, Vermont becomes the first state to legalize marijuana through the legislative process.

Hemp

Arizona Governor Vetoes Hemp Bill. Gov. Doug Ducey vetoed an industrial hemp bill on Monday. Ducey said he vetoed Senate Bill 1337 because it did not provide funding for the state Agriculture Department to administer the program.

Drug Policy

Trump Backs Away From De-Funding the Drug Czar's Office. President Trump has reversed a proposal to cut 95% of the funding for the Office of National Drug Control Policy (ONDCP -- the drug czar's office). In his budget proposal released Tuesday, ONDCP funding is still reduced, but only by 3%, in line with other non-defense-related spending cuts.

Harm Reduction

San Francisco Supervised Injection Site Task Force Launched. A 15-member task force charged with developing a report to the Board of Supervisors on the feasibility and potential costs and benefits of a supervised drug consumption site got to work on Monday. The task force will meet three times over the next three months before issuing its report. The city has bout 22,000 injection drug users and a hundred overdose deaths a year, mostly from heroin and opioids.

Chronicle AM: NJ Legalization Bill Filed, Seattle Safe Injection Sites Face NIMBY, More... (5/15/17)

A new Jersey state senator wants to legalize marijuana, and so do Britain's Liberal Democrats; Seattle's proposed safe injection sites face NIMBY opposition, violence flares in Mexico and threatens to erupt in Colombia, and more.

Colombian President Juan Manuel Santos helps eradicating the first of many coca plants. (President’s Office)
Marijuana Policy

Nevada Legislature Approves Bill Outlawing Urine Testing of Suspected Pot-Impaired Drivers. Lawmakers last Thursday gave final approval to Assembly Bill 135, which would bar the use of urine tests for driving under the influence of marijuana because the science shows that urinalysis does not actually measure impairment -- merely the presence of marijuana metabolites. Under the bill, drivers suspected of being under the influence of pot would be subjected to a blood test, which actually measures THC levels (although not impairment). The bill does not change the state's per se DUID level of two nanogram of THC per milliliter, which presumes drivers are impaired at that level.

New Jersey Legalization Bill Rolled Out Today. State Sen. Nicholas Scutari (D-Linden) on Monday introduced a legalization bill, even though he conceded it was unlikely to become law while Gov. Chris Christie (R) is still around. Christie's term ends in January. The bill would allow the possession of up to an ounce, 16 ounces of edibles, and 72 ounces of marijuana-infused beverages, but would not allow personal cultivation. The bill would also create a Division of Marijuana Enforcement to regulate marijuana commerce, with a sales tax of 7%, rising to 25% over five years. The bill is not yet available on the legislative website.

Medical Marijuana

Iowa Governor Signs CBD Cannabis Oil Expansion Bill. Gov. Terry Branstad (R) last Friday signed into law House File 524, which expands an existing law that allows people with certain conditions to use CBD cannabis oil, but did not allow for production or sale of the oil. The new law lets the state authorize up to two facilities to grow marijuana and produce cannabis oil to be sold in five state-approved dispensaries. It also expands the list of qualifying illnesses to include 15 chronic conditions.

Harm Reduction

Seattle Supervised Injection Sites Face NIMBY Opposition. Opponents of proposed supervised injection sites -- one in Seattle and one possibly in suburban King County -- have organized a local initiative campaign to put the proposal to a county-wide vote. Initiative 27 needs some 47,000 valid voter signatures by July 31 to put the proposal to an up or down vote on the November 2017 ballot.

International

Colombian Government Begins Coca Eradication, Narcos Begin Fight-Back. President Juan Manuel Santos took part last Thursday in the kickoff of a campaign to eradicate coca crops and provide substitutes. The government wants to eradicate some 125,000 acres of coca -- more than three times the amount eradicated last year -- but with the FARC now demobilized, drug traffickers and militias are now waging a campaign of threats, intimidation, and violent attacks to protect their business, leaving coca growers caught between the government and the narcos. Nearly three dozen rural community leaders have been assassinated since the November peace deal, and the traffickers seems to be tailing government officials trying to sell the program. In one Putomayo town last week, anonymous pamphlets threatening cooperative leaders appeared the next day.

Mexican Cartel Fight Over Reynosa "Plaza" Leaves More Than Two Dozen Dead. As of late last week, at least 28 people had been killed in fighting among drug traffickers over who would control "la plaza" (the franchise) in the Mexican border town of Reynosa. The dead include cartel members, civilians, and members of the military. The combatants are variously described as either members of the Zetas and Gulf cartels or factions of the Zetas.

British Lib Dems Embrace Marijuana Legalization. The Liberal Democrats have adopted a platform that includes legalizing marijuana and marijuana commerce. The Lib Dems were the third force in British politics behind Labor and the Conservatives, but saw their number of MPs drop dramatically in the most recent elections after joining the Tories as a junior partner in a coalition government. The Lib Dems are now the fourth force in British politics, having been surpassed by the Scottish Nationalists in the last election.

Chronicle AM: VT Lawmakers Pass Legalization, Sessions May Restart Harsh Drug War, More... (5/10/17)

A bill legalizing the possession and cultivaiton of small amounts of marijuana has passed the Vermont legislature, Attorney General Sessions could be on the verge of reinstating harsh drug war prosecution practices, Mexico's drug violence is on the upswing, and more.

The Vermont legislature made history today becoming the first to have both houses approve a legalization bill. (Wikimedia)
Marijuana Policy

Vermont Legislature Passes Legalization Bill. The state becomes the first in the nation to have both chambers of the legislature approve a marijuana legalization bill after the House voted on Wednesday to approve Senate Bill 22, a compromise between a House bill that would only legalize possession and cultivation -- not commerce -- and a Senate bill that envisioned a full-blown tax and regulate law. This bill postpones the effective date of personal legalization to next year and creates a commission to study whether to advance on taxation and regulation. The bill has already passed the Senate and now heads to the desk of Gov. Phil Scott (R). It is unclear whether Scott will sign the bill or not.

Medical Marijuana

Texas Medical Marijuana Bill Dies. Despite the strongest support yet in Austin, the fight to pass a medical marijuana bill is over. House Bill 2107 is dead, killed by the House Calendars Committee, which failed to take action on it by a Tuesday deadline.

Asset Forfeiture

Iowa Governor Signs Asset Forfeiture Reform Bill. Gov. Terry Branstad (R) on Tuesday signed into law Senate File 446, which requires a criminal conviction before property valued at less than $5,000 can be seized by police. The new law also raises the standard of proof from a preponderance of the evidence to "clear and convincing" evidence, and implements record-keeping requirements.

Drug Policy

Attorney General Sessions Could Bring Back Harsh Drug War Prosecutions. Sessions is reviewing policy changes that could reverse Obama era sentencing practices aimed at reducing the federal prison population. According to reports, Sessions could be on the verge of reversing an Eric Holder memo that instructed prosecutors to avoid charging low-level defendants with crimes carrying the most severe penalties and to avoid seeking mandatory minimum sentences. "As the Attorney General has consistently said, we are reviewing all Department of Justice policies to focus on keeping Americans safe and will be issuing further guidance and support to our prosecutors executing this priority -- including an updated memorandum on charging for all criminal cases," Ian Prior, a department spokesman, in a statement to The Washington Post.

Drug Testing

Labor Department Removes Obama Rule Blocking States' Drug Testing for Unemployment Benefits. The department will publish in the Federal Register on Thursday notice that it is officially removing the Obama era rule that limited states' ability to force unemployment applicants to undergo drug testing. Congress had repealed the rule under the Congressional Review Act in March.

International

Irish Senators Approve Supervised Injection Sites. The Seanad on Wednesday approved legislation permitting the creation of supervised injection sites with a bill that will allow for the preparation and possession of drugs on such premises. The measure was approved by the lower house, the Dail, in March.

Mexico's Drug War Was World's Second Deadliest Conflict Last Year. Some 23,000 people were killed in prohibition-related violence in Mexico last year, making the country second only to Syria in terms of lives lost to conflict. About 50,000 were reported killed in the Syrian civil war in 2016. The numbers come from an annual survey of armed conflict from the International Institute for Strategic Studies. "The wars in Iraq and Afghanistan claimed 17,000 and 16,000 lives respectively in 2016, although in lethality they were surpassed by conflicts in Mexico and Central America, which have received much less attention from the media and the international community," said Anastasia Voronkova, the editor of the survey. Last year's toll is a dramatic increase from the 15,000 conflict deaths in Mexico in 2014 and the 17,000 in 2015. "It is noteworthy that the largest rises in fatalities were registered in states that were key battlegrounds for control between competing, increasingly fragmented cartels," she said. "The violence grew worse as the cartels expanded the territorial reach of their campaigns, seeking to 'cleanse' areas of rivals in their efforts to secure a monopoly on drug-trafficking routes and other criminal assets."

Colombian Coca Production More Than Triples. Thanks largely to "perverse incentives" linked to the end of the decades-long conflict between the Colombian state and the FARC, Colombia is growing more coca than ever. As a result, the cocaine market is saturated, prices have crashed, and unpicked coca leaves are rotting in the fields. "We've never seen anything like it before," said Defense Minister Luis Carlos Villegas. The country produced a whopping 710 tons of cocaine last year, up from 235 tons three years earlier.

Chronicle AM: Dr. Bronner's $5 Million for MDMA Research, HRW Says More Naloxone, More... (4/27/17)

FDA-approved research on MDMA and PTSD gets a big monetary bump courtesy of Dr. Bronner's, Human Right Watch condemns the failure to make the opioid overdose reversal drug naloxone more available, a safe injection site bill is moving in California, and more.

Dr. Bronner's CEO (Cosmic Engagement Officer) David Bronner (maps.org)
Industrial Hemp

Nevada Senate Unanimously Approves Hemp Bill. The Senate has approved Senate Bill 396 by a unanimous vote. The bill would expand on existing state law, which allows colleges or the state Agriculture Department to grow hemp for research purposes. This bill would create "a separate program for the growth and cultivation of industrial hemp and produce agricultural hemp seed in this State," allowing the crop to be grown for commercial purposes. The bill now heads to the House.

Ecstasy

Dr. Bronner's Kicks In $5 Million for MDMA PTSD Research. Dr. Bronner's -- the family-owned maker of the popular soap brand -- is donating $5 million over five years to the Multidisciplinary Association for Psychedelic Studies (MAPS) to pursue its FDA-approved Stage 3 studies of the efficacy of MDMA for treating Post Traumatic Stress Disorder (PTSD). The announcement came ahead of last week's MAPS-sponsored psychedelic science conference in Oakland. "There is tremendous suffering and pain that the responsible integration of MDMA for treatment-resistant PTSD will alleviate and heal," said Dr. Bronner's CEO David Bronner. "To help inspire our allies to close the funding gap, my family has pledged $1 million a year for five years -- $5 million total-- by far our largest gift to an NGO partner to date. In part, we were inspired by the incredible example of Ashawna Hailey, former MAPS Board member, who gave MAPS $5 million when she died in 2011."

Drug Policy

Human Rights Watch Report Says US Drug Policy Failures Drive Preventable Drug Overdose Deaths. The US federal and state governments are taking insufficient action to ensure access to the life-saving medication naloxone to reverse opioid overdose, resulting in thousands of preventable deaths, Human Rights Watch said in a report released Thursday. The 48-page report, "A Second Chance: Overdose Prevention, Naloxone, and Human Rights in the United States," identifies federal and state laws and policies that are keeping naloxone out of the hands of people most likely to witness accidental overdoses, denying them the ability to save lives. "The easiest, most effective step that the federal and state governments can take to stem the tide of deaths from opioid overdoses is to make naloxone easier to get," said Megan McLemore, senior health researcher at Human Rights Watch. "Naloxone should be as easy to get as Tylenol. Criminal laws block access to harm reduction programs such as syringe exchanges; the price of the medication is too high; it is not available over the counter -- these and other obstacles are keeping naloxone out of the hands of those who need it the most."

Harm Reduction

California Committee Votes for Supervised Consumption Sites Bill. A bill supported by the Drug Policy Alliance, Assembly Bill 186, passed Assembly Public Safety Committee on Tuesday. It had already been approved by the Assembly Health Committee last month, which marked the first time a US legislative body has ever approved a safe drug consumption site measure. "This is a huge step toward establishing a more effective, treatment-focused approach to drug addiction and abuse in California," said bill sponsor Assemblymember Susan Talamantes Eggman (D-San Joaquin County). "The committee's input has done a great deal to refine the bill since I first introduced it last year, and its support clearly demonstrates the legislature's willingness to consider bold ideas to get people to treatment and counseling, to protect public health and safety and, most importantly, to save lives." The bill now heads for an Assembly floor vote.

Chronicle AM: Nevada MJ Bills Moving, NY Safe Consumption Campaign Underway, More... (4/26/17)

A group of DAs have published a report critical of marijuana legalization, Nevada marijuana bills are moving, a New York campaign for the establishment of safe drug consumption rooms gets underway, and more.

Will El Chapo pay for the border wall? Ted Cruz thinks it's a swell idea.
Marijuana Policy

In New Report, Prosecutors Slam Marijuana Legalization. The National District Attorneys' Association has released a report, Marijuana Policy: The State and Local Prosecutors' Perspective, that criticizes legalization as leading to greater access by children and creating challenges for impaired driving enforcement. The DAs also criticized state-level legalization and decriminalization as "an obstacle to the comprehensive federal framework." The report will be used by the Trump administration to help fashion its marijuana policy.

Massachusetts House Passes Bill Barring Use of Cash Welfare Benefits to Buy Pot. The House on Tuesday passed House Bill 3194, which would bar the use of cash welfare benefits to purchase marijuana. State law already prohibits cash benefits from being used to purchase alcohol, lottery tickets, cigarettes, and pornography. The measure now goes to the Senate.

Nevada Marijuana Bills Advance. In a frenzy of last-minute activity, legislators approved a series of marijuana bills on Tuesday. Senate Bill 375, which advocates for tribes' right to establish marijuana facilities; Senate Bill 344, which establishes packaging standards; Senate Bill 236, which would allow for on-site consumption; and Senate Bill 374, which would allow the use of medical marijuana for opioid addiction, all passed the Senate and head for the Assembly. Meanwhile, the Assembly passed Assembly Bill 259, which would allow courts to seal the records of people charged with possessing an ounce or less. That bill now heads for the Senate.

Medical Marijuana

Florida Medical Marijuana Regulation Bill Wins Committee Vote. The House Health and Human Services Committee on Monday approved House Bill 1397, which aims to regulate the state's voter-approved medical marijuana system. Critics call the House bill too restrictive and are calling on legislators to instead support a rival bill in the Senate.

Drug Policy

Ted Cruz Files Bill to Make El Chapo Pay for the Border Wall. US Sen. Ted Cruz (R-TX) has filed Senate Bill 939, "to reserve any amounts forfeited to the US government as a result of the criminal prosecution of Joaquin Archivaldo Guzman Loera (commonly known as "El Chapo"), or of other felony convictions involving the transportation of controlled substances into the United States, for security measures along the Southern border, including the completion of a border wall.

Harm Reduction

Safe Shape Tour across New York State Calls for "Safer Consumption Spaces" to Combat Skyrocketing Overdoses. In response to New York State's overdose and opioid epidemic, a coalition of healthcare professionals, public health experts, advocates, and people with a history of drug use are launching a statewide campaign calling for the creation of safer consumption spaces (SCS) supervised injection facilities (SIF) where people can legally consume previously-purchased illicit drugs with supervision from peers and healthcare professionals who help make their use safer and connect them with medical care, drug treatment, and social services. Click on the link for much more information and how to register for events.

Chronicle AM: Israel Cabinet Approves MJ Decrim, NM Senate Approves MJ Decrim, More... (3/6/17)

Legalization bills are getting hearings on the East Coast, decriminalization advances in New Mexico and Israel, a Wyoming edibles penalty bill is dead, and more.

Marijuana Policy

Connecticut Legalization Bill Gets Hearing Tomorrow. The General Assembly's Public Health Committee has a hearing set for House Bill 5314, cosponsored by Rep. Melissa Ziobron (R-East Haddam). The bill would legalize marijuana for people 21 and over, set up a regulatory system for marijuana cultivation and sales, and set up a tax system for marijuana commerce. Other legalization bills proposed by Democrats are awaiting action.

Maryland Legalization Bills Get Hearing. Supporters and foes of marijuana legalization testified before the Senate Judicial Proceedings Committee last Thursday on Senate Bill 927, which would tax and regulate legal marijuana sales, and on Senate Bill 891, which would set up a referendum to amend the state constitution to allow people 21 and over to possess up to two ounces and grow up to six plants. No votes were taken.

New Mexico Senate Approves Decriminalization Bill. The Senate voted last Thursday to approve Senate Bill 258, which would decriminalize the possession of up to a half-ounce of marijuana. Between a half-ounce and eight ounces would remain a misdemeanor. The move comes after the legislature rejected outright legalization. The bill is now before the House Consumer and Public Affairs Committee.

North Dakota Legalization Initiative Supporters Will Try Again. Initiative campaigners gave up a few months ago on signature gathering, but now say they will try again and are aiming at getting a measure on the 2018 ballot. Campaigners said they would have a new petition later this spring or summer.

Wyoming Bill to Set Edibles Penalties Dies Amidst Discord. A conference committee of House and Senate members was unable to reach agreement on how to punish the possession of marijuana edibles, killing House Bill 197. The bill had sought to close a loophole in state law that left it unclear how to punish edibles possession, but originally also included sentencing reductions for marijuana in its plant form. That provision was intended to make the bill palatable to Democratic lawmakers, but it was stripped out of the bill in the Senate. The bill died when the House rejected the Senate version.

Medical Marijuana

Arkansas Medical Marijuana "Fix" Bills Are Moving. The Senate sent two medical marijuana bills to the governor's desk last Thursday, while the House passed three more bills and sent them to the Senate. Winning final legislative approval were House Bill 1556, which bars the use of teleconferencing to certify a patient for medical marijuana, and House Bill 1402, which would allow the state to reschedule marijuana if the federal government does it first. Meanwhile, the Senate will now take up House Bill 1580, which imposes a 4% sales tax on cultivation facilities and a 4% sales tax on dispensary sales; House Bill 1436, which sets an expiration date for dispensary licenses, and House Bill 1584, which would led regulators issue temporary dispensary or cultivation licenses when the original owner ceases to be in control of the business.

West Virginia Medical Marijuana Bills Filed. Sen. Patricia Rucker (R-Jefferson) and 11 cosponsors have filed Senate Bill 386 and companion legislation in the House that would allow for the medical use of marijuana by patients with one of a list of qualifying disorders.

Asset Forfeiture

Mississippi Senate Approves Asset Forfeiture Reform Bill. The Senate voted unanimously last Thursday to approve House Bill 812, which will require law enforcement to report on all forfeitures and creates a new asset forfeiture warrant system under which a judge would have to authorize seizures. The bill had already passed both houses, but had to go back to the Senate for a housekeeping vote. It now head to the desk of Gov. Phil Bryant (R).

International

Israeli Cabinet Approves Marijuana Decriminalization. The cabinet has approved the public safety minister's proposal to decriminalize pot possession. Under the proposal, people caught with marijuana would face only administrative fines for their first three offenses, but criminal charges for a fourth. The measure must still be approved by the Knesset.

Durham Police Will Become First in England to Implement Prescription Heroin and Supervised Injection Sites. Police in Durham are set to begin buying pharmaceutical heroin and providing it to addicts, who will inject it twice a day at a supervised injection site. The plan is currently being studied by public health authorities in the region.

Chronicle AM: Quinnipiac Poll Has 59% for Legalization, Trump Could Kill ONDCP, More... (2/23/17)

Yet another national poll has a strong marjority for marijuana legalization, Trump administration cost-cutters eye the drug czar's office, Arizona pot legalizers refine their 2018 initiative, and more.

Going, going, gone?
Marijuana Policy

Quinnipiac Poll Has Support for Legalization at 59%. A new Quinnipiac poll has support for marijuana legalization nationwide at 59%, with an even larger number -- 71% -- saying the federal government should respect state marijuana laws. The poll also finds support for medical marijuana at stratospheric levels, with 93% in support.

Arizona Initiative Campaign Refines Its Proposal. Safer Arizona has refiled its marijuana legalization initiative after receiving criticism of some parts of it after it was originally filed last week. The new version adds a mandatory 1,000-foot buffer between schools and marijuana operations, makes it a crime -- not a civil offense -- to sell marijuana to minors, makes possession by minors a crime, but with only a $50 civil fine for a first offense, and allows local authorities to impose "reasonable zoning restrictions." The initiative needs 150,000 valid voter signatures by July to qualify for the 2018 ballot.

Wyoming Marijuana Edibles Penalties Bill Gets Tightened. A bill that originally created a tiered penalty system for both marijuana and marijuana edibles earlier had its provisions relating to marijuana removed, and now a Senate committee has further tightened the bill to make possession of more than three grams of edibles a felony and has increased the period for which past offenses would be considered from five years to 10 years. The committee taking a hatchet to House Bill 197 is the Senate Judiciary Committee. The bill had passed the House largely intact.

Medical Marijuana

North Dakota Senate Okays Changes to Voter-Approved Medical Marijuana Initiative. The Senate voted Wednesday to approve Senate Bill 2344, which imposes tougher restrictions and more oversight than the initiative approved by voters in November. The bill sets steep fees for patients and providers and allows the Health Department to inspect patients' homes with 24-hour notice and medical marijuana facilities with no notice. On the upside, it also allows for smoking medical marijuana and lowers the age for classification as minor from 21 to 19. The bill now heads to the House.

Drug Policy

Trump Considers Eliminating ONDCP, the Drug Czar's Office. The White House Office of Management and Budget has proposed cutting nine government programs, including the Office of National Drug Control Policy (ONDCP -- the drug czar's office). Unsurprisingly, the move is generating pushback from law enforcement, the drug treatment complex, and some legislators. Stay tuned.

Drug Testing

Arkansas Welfare Drug Testing Bill Passes House. A bill that would make permanent a pilot program requiring people seeking help from the Temporary Assistance for Needy Families (TANF) program to undergo drug screening and drug testing if deemed likely to be using drugs has passed the House. Senate Bill 123 has already passed the Senate, but now goes back for a housekeeping vote before heading to the governor's desk. The bill passed even though state Health Department officials testified that only two people had actually failed the drug test under the pilot program.

International

Edmonton Awaits Approval of Safe Injection Sites from Canadian Government. The province of Alberta and the city of Edmonton are ready to move ahead with safe injection sites and are now awaiting federal government approval. Local officials unveiled the locations of the proposed sites Wednesday. Last year, the Alberta government announced it would seek a federal exemption to set up "medically supervised injection services," and now it awaits action from the Liberal government in Ottawa.

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School